The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Align Technology Prevails in U.S. Patent Office Proceedings Initiated by ClearCorrect
Feb. 16, 2017 09:50AM PST
Medical Device InvestingAlign Technology, Inc. (NASDAQ: ALGN) today announced that it has prevailed in proceedings initiated by ClearCorrect Operating LLC before the United States Patent and Trademark Office (“USPTO”) that challenged the validity of three of Align’s U.S. patents. Last week, the USPTO issued reexamination certificates confirming the patentability of all challenged claims of Align’s U.S. Patent …
Align Technology, Inc. (NASDAQ: ALGN) today announced that it has prevailed in proceedings initiated by ClearCorrect Operating LLC before the United States Patent and Trademark Office (“USPTO”) that challenged the validity of three of Align’s U.S. patents.
Last week, the USPTO issued reexamination certificates confirming the patentability of all challenged claims of Align’s U.S. Patent Nos. 6,217,325, 6,722,880, and 8,070,487. Align was not required to amend or alter any of the challenged patent claims — they were all confirmed based on the existing claim language. The confirmed patents include two of the patents (the ‘325 and ‘880 patents) that Align is asserting in its patent infringement lawsuit against ClearCorrect pending in the Southern District of Texas. These same two patents previously emerged from a prior reexamination proceeding a decade ago and were also found valid in the recent ITC proceedings against ClearCorrect. Thus, the current reexamination decision marks the third time Align successfully defended these patents. ClearCorrect responded to its latest defeat this week by filing two more reexamination requests regarding the same ‘325 patent that was just confirmed by the USPTO last week.
“These reexaminations have now ended with Align prevailing on every claim of every challenged patent. ClearCorrect’s previous attempts to challenge the validity of Align patents — at trial before the International Trade Commission — also resulted in the rejection of all of ClearCorrect’s invalidity contentions and a finding of validity of all of the asserted patents. Align’s confidence in the validity of its patent portfolio continues to be borne out by the positive rulings of neutral decision makers like the USPTO and the ITC,” said Roger E. George, Align Technology vice president and general counsel.
About Align Technology, Inc.
Align Technology is the leader in modern Clear Aligner orthodontics that designs, manufactures and markets the Invisalign® system, which provides dental professionals with a range of treatment options for adults and teenagers. Align also offers the iTero 3D digital scanning system and services for orthodontic and restorative dentistry. Align was founded in March 1997 and received FDA clearance to market the Invisalign system in 1998. Visit www.aligntech.com for more information.
For additional information about the Invisalign system or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about the iTero 3D digital scanning system, please visit www.itero.com.
Last week, the USPTO issued reexamination certificates confirming the patentability of all challenged claims of Align’s U.S. Patent Nos. 6,217,325, 6,722,880, and 8,070,487. Align was not required to amend or alter any of the challenged patent claims — they were all confirmed based on the existing claim language. The confirmed patents include two of the patents (the ‘325 and ‘880 patents) that Align is asserting in its patent infringement lawsuit against ClearCorrect pending in the Southern District of Texas. These same two patents previously emerged from a prior reexamination proceeding a decade ago and were also found valid in the recent ITC proceedings against ClearCorrect. Thus, the current reexamination decision marks the third time Align successfully defended these patents. ClearCorrect responded to its latest defeat this week by filing two more reexamination requests regarding the same ‘325 patent that was just confirmed by the USPTO last week.
“These reexaminations have now ended with Align prevailing on every claim of every challenged patent. ClearCorrect’s previous attempts to challenge the validity of Align patents — at trial before the International Trade Commission — also resulted in the rejection of all of ClearCorrect’s invalidity contentions and a finding of validity of all of the asserted patents. Align’s confidence in the validity of its patent portfolio continues to be borne out by the positive rulings of neutral decision makers like the USPTO and the ITC,” said Roger E. George, Align Technology vice president and general counsel.
About Align Technology, Inc.
Align Technology is the leader in modern Clear Aligner orthodontics that designs, manufactures and markets the Invisalign® system, which provides dental professionals with a range of treatment options for adults and teenagers. Align also offers the iTero 3D digital scanning system and services for orthodontic and restorative dentistry. Align was founded in March 1997 and received FDA clearance to market the Invisalign system in 1998. Visit www.aligntech.com for more information.
For additional information about the Invisalign system or to find an Invisalign provider in your area, please visit www.invisalign.com. For additional information about the iTero 3D digital scanning system, please visit www.itero.com.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.